Deepika Pakianathan - Feb 5, 2025 Form 4 Insider Report for Mereo BioPharma Group plc (MREO)

Role
Director
Signature
/s/ Christine Fox, by power of attorney
Stock symbol
MREO
Transactions as of
Feb 5, 2025
Transactions value $
$0
Form type
4
Date filed
2/6/2025, 04:30 PM
Previous filing
Aug 23, 2024
Next filing
May 21, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MREO Share Options (Right to buy) Award $0 +55K $0.00 55K Feb 5, 2025 American Depositary Shares 55K $3.16 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date
F2 Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer